Outcome of 31 Intracranial Haemangiopericytomas: Poor Predictive Value of Cell Proliferation Indices

Overview

Journal Acta Neurochir (Wien)

Specialty Neurosurgery

Date 1996 Jan 1

PMID 9030346

Citations 14

Authors

V Vuorinen

P SALLINEN

H Haapasalo

T Visakorpi

M Kallio

J Jaaskelainen

Affiliations

Soon will be listed here.

Abstract

Cell proliferation indices of 31 primary intracranial haemangiopericytomas (HPC) and their recurrences and metastases were correlated with the long-term recurrence, metastasis and survival rates. Paraffin-embedded specimens were used for K-67, PCNA and p53 immunostainings and for estimation of S-phase fraction (S-PF) in flow cytometry. The median Ki-67 and PCNA indices and S-PFs were 10.4, 3.2, and 4.0 for primary HPCs and 14.1, 14.1, and 5.5 for recurrences, respectively. High indices were associated with higher recurrence, metastasis and death rates, but not at the p < or = 0.5 level. Consequently, these indices do not seem useful in planning of treatment and follow-up of meningeal HPCs. Meningeal HPCs, in contrast to meningiomas, recur almost always despite seemingly complete removal and often metastasize elsewhere in the body. This difference between two sharply demarcated tumours must reflect particularly adhesive and infiltrative properties of HPC cells and not just higher proliferation potential.

Citing Articles

Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis.

Golub D, McBriar J, Donaldson H, Wong T, Unadkat P, White T J Neurooncol. 2023; 165(2):229-239.

PMID: 37955760 DOI: 10.1007/s11060-023-04499-w.

Solitary fibrous tumor of the central nervous system invading and penetrating the skull: A case report.

Lin Q, Zhu J, Zhang X Oncol Lett. 2023; 25(2):81.

PMID: 36742362 PMC: 9853498. DOI: 10.3892/ol.2023.13667.

Multidisciplinary Treatment of Liver Metastases from Intracranial SFTs/HPCs: A Report of Three Consecutive Cases.

Krendl F, Messner F, Laimer G, Djanani A, Seeber A, Oberhuber G Curr Oncol. 2022; 29(11):8720-8741.

PMID: 36421340 PMC: 9689021. DOI: 10.3390/curroncol29110687.

The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11).

Lee J, Jeon S, Park C, Park S, Yoon H, Chang J Cancer Res Treat. 2021; 54(1):65-74.

PMID: 33781051 PMC: 8756112. DOI: 10.4143/crt.2021.142.

Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.

Kinslow C, Rajpara R, Wu C, Bruce S, Canoll P, Wang S J Neurooncol. 2017; 133(2):409-417.

PMID: 28447278 DOI: 10.1007/s11060-017-2450-8.

References

Shibuya M, Hoshino T, Ito S, Wacker M, PRADOS M, Davis R . Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery. 1992; 30(4):494-7; discussion 497-8. DOI: 10.1227/00006123-199204000-00004. View

ENZINGER F, Smith B . Hemangiopericytoma. An analysis of 106 cases. Hum Pathol. 1976; 7(1):61-82. DOI: 10.1016/s0046-8177(76)80006-8. View

Munakata S, Hendricks J . Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem. 1993; 41(8):1241-6. DOI: 10.1177/41.8.8331288. View

Cattoretti G, BECKER M, Key G, Duchrow M, Schluter C, Galle J . Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992; 168(4):357-63. DOI: 10.1002/path.1711680404. View

Lee K, Hoshino T, Rodriguez L, Bederson J, Davis R, Wilson C . Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. Acta Neuropathol. 1990; 80(3):311-7. DOI: 10.1007/BF00294650. View

Jellinger K, SLOWIK F . Histological subtypes and prognostic problems in meningiomas. J Neurol. 1975; 208(4):279-98. DOI: 10.1007/BF00312803. View

Haapasalo H, Isola J, SALLINEN P, Kalimo H, Helin H, Rantala I . Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. Am J Pathol. 1993; 142(5):1347-51. PMC: 1886904. View

Chozick B, Pezzullo J, Epstein M, Finch P . Prognostic implications of p53 overexpression in supratentorial astrocytic tumors. Neurosurgery. 1994; 35(5):831-7; discussion 837-8. DOI: 10.1227/00006123-199411000-00005. View

Mena H, Ribas J, Pezeshkpour G, Cowan D, Parisi J . Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol. 1991; 22(1):84-91. DOI: 10.1016/0046-8177(91)90067-y. View

10.

Vojtesek B, Bartek J, Midgley C, Lane D . An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods. 1992; 151(1-2):237-44. DOI: 10.1016/0022-1759(92)90122-a. View

11.

May P, Broome J, Lawry J, Buxton R, Battersby R . The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. J Neurosurg. 1989; 71(3):347-51. DOI: 10.3171/jns.1989.71.3.0347. View

12.

Kallioniemi O, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T . Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry. 1991; 12(5):413-21. DOI: 10.1002/cyto.990120506. View

13.

Lane D . Cancer. p53, guardian of the genome. Nature. 1992; 358(6381):15-6. DOI: 10.1038/358015a0. View

14.

Bravo R, Frank R, Blundell P . Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987; 326(6112):515-7. DOI: 10.1038/326515a0. View

15.

Siitonen S, Kallioniemi O, Isola J . Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol. 1993; 142(4):1081-9. PMC: 1886856. View

16.

Simpson D . The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957; 20(1):22-39. PMC: 497230. DOI: 10.1136/jnnp.20.1.22. View

17.

Khoshyomn S, Maier H, Morimura T, Kitz K, Budka H . Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens. Acta Neuropathol. 1993; 86(6):582-9. DOI: 10.1007/BF00294296. View

18.

Morris G, Mathews M . Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem. 1989; 264(23):13856-64. View

19.

Roggendorf W, Schuster T, PEIFFER J . Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol. 1987; 73(4):361-4. DOI: 10.1007/BF00688260. View

20.

Waseem N, Lane D . Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci. 1990; 96 ( Pt 1):121-9. DOI: 10.1242/jcs.96.1.121. View